Editorial Commentary: Addressing Disparities in HIV Mortality: Antiretroviral Therapy Is Necessary but Not Sufficient

Smith, Kimberly Y.
June 2013
Clinical Infectious Diseases;Jun2013, Vol. 56 Issue 12, p1810
Academic Journal
An introduction is presented in which the editor discusses the study which examines the influence of geographic origin and race/ethnicity on HIV mortality in patients on antiretroviral therapy (ART) in Canada, Europe, and the U.S.


Related Articles

  • HIV-positive people on ART have the same mortality risk to HIV-negative people.  // HIV Australia;2013, Vol. 11 Issue 2, p5 

    The article presents information on a report according to which HIV-positive persons responding well to antiretroviral therapy have no higher mortality risk as compared to their HIV-negative peers.

  • Incidence of Tuberculosis during Highly Active Antiretroviral Therapy in High-Income and Low-Income Countries. Lawn, Stephen D.; Wood, Robin // Clinical Infectious Diseases;12/15/2005, Vol. 41 Issue 12, p1783 

    The article presents the author's comments on the incidence of Tuberculosis during highly active antiretroviral therapy in high-income and low-income countries. Highly active antiretroviral therapy (HAART) has revolutionized the care of HIV-infected individuals, causing major reductions in...

  • Mortality among HIV-Infected Patients in Resource Limited Settings: A Case Controlled Analysis of Inpatient's at a Community Care Center. Rajagopalan, Nirmala; Suchitra, Joyce B.; Shet, Anita; Khan, Zafar K.; Martin-Garcia, Julio; Nonnemacher, Michael R.; Jacobson, Jeffrey M.; Wigdahl, Brian // American Journal of Infectious Diseases;2009, Vol. 5 Issue 3, p219 

    Problem statement: Despite massive national efforts to scale up Antiretroviral Therapy (ART) access in India since 2004, the AIDS death rate was 17.2 per 100,000 persons during 2003- 2005. In the era of HAART in resource poor settings, it is imperative to understand and address the causes of...

  • Sensitivity of chronically HIV-1 infected HeLa cells to electrical stimulation. Kumagai, E.; Tominaga, M.; Harada, S. // Applied Microbiology & Biotechnology;Feb2004, Vol. 63 Issue 6, p754 

    Use of combination anti-retroviral drug regimens including protease inhibitors dramatically decreased morbidity and mortality rates in HIV-1 infected individuals. However, such combination therapies appear to have many side effects, in addition to the emergence of resistant HIV-1 strains....

  • Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act. Robert W. Burgoyne; Darrell H. S. Tan // Journal of Antimicrobial Chemotherapy (JAC);Mar2008, Vol. 61 Issue 3, p469 

    Advances in highly active antiretroviral therapy (HAART) options for people living with HIV/AIDS have resulted in decreased morbidity and mortality. To some extent, the role of disease progression in eroding quality of life (QOL) erosion in the pre-HAART age is now supplanted by drug toxicities,...

  • Free antiretroviral treatment effective in Malawi.  // Infectious Disease News;Jun2008, Vol. 21 Issue 6, p39 

    The article reports on the results of a study on the efficiency of antiretroviral therapy in Malawi. It revealed that mortality rates of patients with HIV and AIDS have been reduced following the introduction of free antiretroviral therapy. According to researchers, the mortality rate was 9.8...

  • Estimating Loss to Follow-Up in HIV-Infected Patients on Antiretroviral Therapy: The Effect of the Competing Risk of Death in Zambia and Switzerland. Schöni-Affolter, Franziska; Keiser, Olivia; Mwango, Albert; Stringer, Jeffrey; Ledergerber, Bruno; Mulenga, Lloyd; Bucher, Heiner C.; Westfall, Andrew O.; Calmy, Alexandra; Boulle, Andrew; Chintu, Namwinga; Egger, Matthias; Chi, Benjamin H. // PLoS ONE;2011, Vol. 6 Issue 12, p1 

    Background: Loss to follow-up (LTFU) is common in antiretroviral therapy (ART) programmes. Mortality is a competing risk (CR) for LTFU; however, it is often overlooked in cohort analyses. We examined how the CR of death affected LTFU estimates in Zambia and Switzerland. Methods and Findings:...

  • Trends and predictors of mortality among HIV positive patients in the era of highly active antiretroviral therapy in Uganda. Rubaihayo, John; Tumwesigye, Nazarius M.; Konde-Lule, Joseph; Makumbi, Fredrick; Nakku, Edith J.; Wamani, Henry; Etukoit, Michael B. // Infectious Disease Reports;2015, Vol. 7 Issue 2, p66 

    Knowledge of mortality trends and predictors among HIV-positive patients in the era of highly active antiretroviral therapy (HAART) in resource poor settings is still limited. The aim of this study was to describe trends and predictors of mortality among HIV-positive patients in the era of HAART...

  • Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. Johannessen, Asgeir; Naman, Ezra; Ngowi, Bernard J.; Sandvik, Leiv; Matee, Mecky I.; Aglen, Henry E.; Gundersen, Svein G.; Bruun, Johan N. // BMC Infectious Diseases;2008, Vol. 8 Issue 1, Special section p1 

    Background: Studies of antiretroviral therapy (ART) programs in Africa have shown high initial mortality. Factors contributing to this high mortality are poorly described. The aim of the present study was to assess mortality and to identify predictors of mortality in HIV-infected patients...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics